CalcMyPeptide
Recovery & HealingAlso known as: Mechano Growth Factor, IGF-1Ec

MGF

Natural IGF-1 splice variant (IGF-1Ec) produced locally in damaged muscle tissue to initiate satellite cell activation.

Half-Life
~5-7 minutes
Dose Range
100-200 mcg per site
Frequency
1× daily (post-training)
Vial Sizes
2 mg, 5 mg

🔬 Mechanism of Action

MGF (Mechano Growth Factor, IGF-1Ec) is a splice variant of IGF-1 produced locally in damaged muscle tissue. When muscle fibers experience mechanical load and damage, the IGF-1 gene is spliced differently, producing MGF instead of systemic IGF-1.

MGF activates satellite cells at the injury site, initiating the muscle repair and regeneration process. Its extremely short half-life (~5-7 minutes) means it acts as a local signal — it must be injected directly into or near the target muscle to be effective.

Source: PMID: 12620066

📜Background & History

MGF (Mechano Growth Factor) is the native, non-PEGylated splice variant of IGF-1 generated after mechanical load or injury. It contains a unique 24-amino-acid E-domain that distinguishes it from systemic IGF-1 and specifically activates quiescent muscle satellite cells. The E-domain peptide has also been shown to have direct cardiac and neuroprotective effects independent of satellite cell activation. Its 2-minute half-life in blood means local injection near muscle is essential for activity.

🎯 Research Use Cases

  • Immediate post-injury satellite cell activation (inject locally)
  • Cardiac protection post-ischemia via independent E-domain mechanism
  • Neuroprotection in CNS injury models

💉 Dosing Protocol

Typical Dose100-200 mcg per site
Frequency1× daily (post-training)
Half-Life~5-7 minutes
Common Vial Sizes2 mg, 5 mg

🧪 Reconstitution Example

Vial
2 mg
Water
2 mL
Concentration
1 mg/mL
Per Unit (100u syringe)
10 mcg
Dose of 100 mcg = 10 units on a 100-unit insulin syringe

⚠️Safety & Considerations

Research peptide. Must be injected locally (intramuscular or subcutaneous near target). Very short half-life means systemic injection is ineffective. Use immediately after reconstitution for best results.

Interactions & Contraindications

Must be injected directly into or near target muscle tissue due to 2-minute serum half-life. No systemic activity from non-local injection. As an IGF-1 family peptide: contraindicated with active cancer. Localized hypoglycemia risk at injection site is minimal.

🔗Synergies & Common Stacks

+ PEG-MGF

MGF provides immediate local satellite cell activation (short burst); PEG-MGF extends this signal for 48-72 hours. Sequential protocol for maximum muscle repair.

+ IGF-1 LR3

MGF activates satellite cells; IGF-1 LR3 drives them to proliferate and differentiate. Complete myogenic cascade activation.

MGF dosing guide infographic showing dose range 100-200 mcg per site, half-life ~5-7 minutes, and reconstitution example
MGF dosing quick reference — 100-200 mcg per site, 1× daily (post-training)

Frequently Asked Questions

Why must MGF be injected locally?
MGF has a ~5-7 minute half-life — it is degraded too quickly to provide systemic effects. Local injection delivers it directly to satellite cells at the repair site. For systemic use, PEG-MGF is the alternative.
When should I inject MGF?
Immediately post-training, injected intramuscularly or subcutaneously near the target muscle. This mimics the natural MGF response to mechanical muscle damage.

📖 References

  1. Goldspink G. Mechano growth factor splice variant of IGF-I and muscle repair.” J Physiol (2005). PMID: 15845583

📚 Related Articles